Mg0002 712 — Los Angeles, California

Mg0002 712 is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mg0002 712 has participated in 1 clinical trials.

Therapeutic areas: Myasthenia Gravis.

Sponsors: UCB Biopharma S.P.R.L..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mg0002 712?

Mg0002 712 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mg0002 712 conducted?

Mg0002 712 has 1 clinical trials on record. Their work covers Myasthenia Gravis.

Is Mg0002 712 accredited by Crixeo Health?

Mg0002 712 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mg0002 712?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.